Skip to main content

Table 2 Study cohort

From: Anaphylactic reactions in the build-up phase of rush immunotherapy for bee venom allergy in pediatric patients: a single-center experience

Variable N (%)
No. of patients 19  
Age in years
 Median 9  
 Minimum 4  
 Maximum 14  
Pre-existing conditions 4 (21.1%)
 Other allergies 1  
 Autoimmune 2  
 Hematological 1  
Grade of anaphylactic reaction to initial field sting
 Grade I 3  
 Grade II 8  
 Grade III 8  
 Grade IV 0  
Anaphylactic reaction to rush immunotherapy 3 (15.8%)
 Grade I 1  
 Grade II 2  
 Grade III 0  
 Grade IV 0